SNSE vs RNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 30, 2026

SNSE

52.5
AI Score
VS
RNA Wins

RNA

59.8
AI Score

Investment Advisor Scores

SNSE

53score
Recommendation
HOLD

RNA

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SNSE RNA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -21.9% SNSE
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 52.5/100 59.8/100 RNA
Profit Margin 0.0% -184.1% SNSE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

SNSE 1M: -30.1% · 3M: -53.7% RNA 1M: -44.2% · 3M: -39.7%

Current Technical Phase

SNSE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.8%), weak momentum, RSI 39

RSI (14): 38.6 · Price: $13.85

RNA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.2%), weak momentum, RSI 23

RSI (14): 23.3 · Price: $7.84

Fundamentals Snapshot

Metric SNSE RNA
Market Cap — —
Forward P/E -1.8 -1.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.2%
Gross Margin — -0.6%
Operating Margin 0.0% -7.5%
EPS -142.72 -5.35
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.